F R Spitz
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer-related Molecular Pathways
- Biotechnology top 5%
- Cancer Research and Treatments
Papers in
- Co-authors
- Richard J. Cristiano (3 shared papers)Nora A. Janjan (1 shared paper)J E Lee (1 shared paper)Tyvin A. Rich (1 shared paper)Douglas B. Evans (1 shared paper)Karen R. Cleary (1 shared paper)Peter W. T. Pisters (1 shared paper)Claudia J. Fenoglio (1 shared paper)
- Journals
- European Journal of Surgical Oncology (1 paper)Journal of Clinical Oncology (1 paper)Annals of Surgical Oncology (1 paper)Journal of Endocrinological Investigation (1 paper)PubMed (3 papers)
- Partner nations
- United States
In The Last Decade
F R Spitz
7 papers receiving 674 citations
Peers
Comparison fields: 5 of 44
- Oncology 583
- Biotechnology 131
- Cancer Research 145
- Pulmonary and Respiratory Medicine 215
- Epidemiology 200
Countries citing papers authored by F R Spitz
This map shows the geographic impact of F R Spitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F R Spitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F R Spitz more than expected).
Fields of papers citing papers by F R Spitz
This network shows the impact of papers produced by F R Spitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F R Spitz. The network helps show where F R Spitz may publish in the future.
Co-authors
The 25 scholars most cited alongside F R Spitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 421 | |
| 2 | Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. | 1996 | 141 |
| 3 | In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. | 1997 | 73 |
| 4 | High levels of gene transduction in human lung tumors following intralesional injection of recombinant adenovirus. | 1996 | 27 |
| 5 | 2016 | 12 | |
| 6 | 2022 | 6 | |
| 7 | 2004 | 6 |
About F R Spitz
F R Spitz is a scholar working on Oncology, Genetics, Epidemiology, Biotechnology and Cancer Research, having authored 7 papers that have together received 686 indexed citations. Recurring topics across this work include Virus-based gene therapy research (3 papers), Cancer Research and Treatments (2 papers), Cancer-related Molecular Pathways (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Cancer Genomics and Diagnostics (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and TGF-β signaling in diseases (1 paper). The work is most often cited by research in Oncology (583 citations), Biotechnology (131 citations), Cancer Research (145 citations), Pulmonary and Respiratory Medicine (215 citations) and Epidemiology (200 citations). F R Spitz has collaborated with scholars based in United States. Frequent co-authors include Richard J. Cristiano, Nora A. Janjan, J E Lee, Tyvin A. Rich, Douglas B. Evans, Karen R. Cleary, Peter W. T. Pisters, Claudia J. Fenoglio, James L. Abbruzzese and Andrew M. Lowy. Their work appears in journals such as European Journal of Surgical Oncology, Journal of Clinical Oncology, Annals of Surgical Oncology, Journal of Endocrinological Investigation and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.